Characteristics and survival of patients with Wilms tumor and bone metastases: a SIOP-RTSG 93-01, SIOP 2001, and UK-IMPORT Study
Background Wilms tumor (WT) has an excellent outcome. Studies suggest that patients with WT and bone metastases (WT-BM) have a poor prognosis. This analysis describes the characteristics and outcome of patients with WT-BM, registered by the International Society of Paediatric Oncology—Renal Tumor St...
Salvato in:
| Autori principali: | , , , , , , , , , , , , , , , , |
|---|---|
| Natura: | Article (Journal) |
| Lingua: | inglese |
| Pubblicazione: |
July 2026
|
| In: |
Pediatric blood & cancer
Year: 2026, Volume: 73, Fascicolo: 7, Pages: 1-7 |
| ISSN: | 1545-5017 |
| DOI: | 10.1002/1545-5017.70270 |
| Accesso online: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/1545-5017.70270 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/1545-5017.70270 |
| Note sull'autore: | Arianna Tagarelli, Rana Dandis, Harm Van Tinteren, Rhoikos Furtwängler, Reem Al-Saadi, Tanzina Chowdhury, Gema Lucia Ramirez-Villar, Beatriz de Camargo, Jens-Peter Schenk, Roberto Augusto Plaza Teixeira, Martine van Grotel, Jesper Brok, Herve J. Brisse, Annalisa Serra, Norbert Graf, Arnauld Verschuur, Marry M. van den Heuvel-Eibrink |
| Riassunto: | Background Wilms tumor (WT) has an excellent outcome. Studies suggest that patients with WT and bone metastases (WT-BM) have a poor prognosis. This analysis describes the characteristics and outcome of patients with WT-BM, registered by the International Society of Paediatric Oncology—Renal Tumor Study Group (SIOP-RTSG) and UK-IMPORT STUDY. Methods We retrospectively assessed clinical characteristics and outcome of patients with WT-BM at diagnosis treated according to SIOP-RTSG 93-01, SIOP 2001/UK-IMPORT study protocols. Results Among 7399 patients diagnosed with WT between 1993 and 2019, 47 were identified with WT-BM (12 males/35 females), accounting for 3.3% of stage IV-WT. The median age at diagnosis was 63 months (24-292 months). Four patients (9%) had only BM involvement and 43 patients (91%) had multisite metastases. Local stage was I-II in 15 (32%) patients, stage III in 26 (55%) patients, and unknown in 6 (13%) patients. Preoperative chemotherapy consisted of three drugs in 95% of cases with available data (38/40). Histological subtyping identified low-risk (LR, n = 4), intermediate-risk (IR, n = 29), high-risk (HR, n = 7) tumors, unknown/others in seven patients. The majority had postoperative treatment according to protocol. Among 35 patients with data, 33 (94%) received any kind of radiotherapy. EFS and OS were 67% and 74% at 2 years, decreasing to 64% and 62% at five years. EFS at 2 years was 14% in the HR group and 84% in the IR group. Conclusions WT-BM is a rare condition. Awareness of its existence and multimodality treatment are warranted. |
|---|---|
| Descrizione del documento: | Zuerst veröffentlicht: 20. April 2026 Gesehen am 16.06.2026 |
| Descrizione fisica: | Online Resource |
| ISSN: | 1545-5017 |
| DOI: | 10.1002/1545-5017.70270 |